Press Releases

Recent & Archived News

November 26, 2018

FDA Approves Vitrakvi® (larotrectinib), the First Ever TRK Inhibitor, for Patients with Advanced Solid Tumors Harboring an NTRK Gene Fusion(1,2)

The U.S. Food and Drug Administration (FDA) today approved Vitrakvi® (larotrectinib), the first ever oral TRK inhibitor, for the treatment of adult and pediatric patients with solid tumors that...

Learn more
November 19, 2018

The Climate Corporation Partners with Farmers Mutual Hail, Simplifies Crop Insurance Reporting for U.S. Farmers

The Climate Corporation, a subsidiary of Bayer, today announced a platform agreement with Farmers Mutual Hail Insurance Company of Iowa (FMH), enabling farmers to connect their field data to FMH...

Learn more
November 14, 2018

Increased Consumer Risks from Purchasing Erectile Dysfunction Medicine on the Gray Market Exposed in New Research

Bayer and the National Consumers League (NCL) today released a white paper, Increased Consumer Risk from Erectile Dysfunction Medication Advertised and Sold on the Gray Market, which exposes the...

Learn more
November 09, 2018

Bayer Names Finalists in Second Annual Alka-Rocket Challenge

Universities across the United States have spent months designing and constructing their Alka-Rocket in hopes of becoming a finalist in the Bayer Alka-Rocket challenge. For five university teams...

Learn more
November 08, 2018

Pivot Bio, Bayer Announce Research Collaboration To Enhance Soybean Inoculant

Pivot Bio and Monsanto Company, a member of the Bayer Group, announced today a collaboration entered into earlier this year to develop Bradyrhizobium strains with enhanced nitrogen production for...

Learn more
November 08, 2018

New survey finds about half of U.S. patients may have 'scanxiety' about diagnostic imaging procedures

In honor of today's International Day of Radiology, Bayer announced results from a global survey involving over 1,000 patients across seven countries to assess the patient experience with magnetic...

Learn more
October 31, 2018

EPA Issues Continued Registration for XtendiMax® Herbicide with VaporGrip® Technology

Today, the Environmental Protection Agency (EPA) announced a continued registration, including label changes, for XtendiMax® Herbicide with VaporGrip® Technology, following an extensive review....

Learn more
October 24, 2018

Phase III Trial of Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint

The Phase III ARAMIS (Androgen Receptor inhibiting Agent for MetastatIc-free Survival) trial that investigated darolutamide in men with non-metastatic castration-resistant prostate cancer...

Learn more
October 21, 2018

Larotrectinib Delivers 81% Overall Response Rate in an Expanded Dataset of 109 TRK Fusion Cancer Patients Across Ages and Tumor Types

Bayer and Loxo Oncology, Inc. (Nasdaq: LOXO), today announced updated clinical data for larotrectinib in adult and pediatric patients with TRK fusion cancer across 24 unique tumor types. The...

Learn more
October 16, 2018

Bayer U.S. Appoints Scott Partridge General Counsel

Scott Partridge, former vice president of global strategy for Monsanto, now part of Bayer, has been named the company's U.S. General Counsel. Partridge, who succeeds former General Counsel Jan...

Learn more


Want even more Bayer news?

Check out our Social Media & Blogs.